Trade Mark Journal No.2026/046 13 November 2026
WO0000001945122 (42)
Office of origin: United States of America
Date of International Registration:29 September 2026
Date of designation in the UK:
29 September 2026

International priority date claimed: 28 April 2026
(United States of America)
(99791115)
- Class 42
- Pharmaceutical drug development services; research and development of drug conjugates; pharmaceutical products development; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services of new pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; research and development in the field of pharmaceuticals; research and development of new products in the field of pharmaceuticals.
ASTRIZI BIO INC.
Representative: Douglas Lee Lineberry Maynard Nexsen, 104 South Main Street,, Suite 900, Greenville SC 29601, UNITED STATES OF AMERICA